Minerva Neurosciences, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Minerva Neurosciences, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 710% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 89% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
85%Of every $100 the company owns, $85 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 55% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (7)
Minerva Neurosciences, Inc. made a loss over the last year. Minerva Neurosciences, Inc. owes $3.24 for every $1 it owns. Minerva Neurosciences, Inc. made a loss in the year to Dec 2025, after a profit the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossMinerva Neurosciences, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-0.54Minerva Neurosciences, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$115 MThe total market value of all of Minerva Neurosciences, Inc.'s shares at today's price (share price × number of shares), smaller than 64% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
NegativeMinerva Neurosciences, Inc.'s net worth is negative ($213 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
3.24×Minerva Neurosciences, Inc. owes $3.24 for every $1 it owns, so it owes more than it owns, higher than 98% of Healthcare companies in United States.
Dividend yield
NoneMinerva Neurosciences, Inc. does not currently pay a dividend.
Profit growth
LossMinerva Neurosciences, Inc. made a loss in the year to Dec 2025, after a profit the year before.
Questions
How much does Minerva Neurosciences, Inc. owe compared with what it owns?
Minerva Neurosciences, Inc. owes $3.24 for every $1 it owns, so it owes more than it owns, higher than 98% of Healthcare companies in United States.
Does Minerva Neurosciences, Inc. pay a dividend?
No. Minerva Neurosciences, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.